Argenx
ARGX
#492
Rank
ยฃ37.38 B
Marketcap
ยฃ598.28
Share price
-0.06%
Change (1 day)
41.91%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2026 (TTM): ยฃ1.11 Billion

According to Argenx 's latest financial reports the company's current earnings are ยฃ4.66 Billion. In 2025 the company made an earning of ยฃ0.94 Billion, an increase over its 2024 earnings that were of ยฃ62.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ1.11 B18.75%
2025 ยฃ0.94 B1400.64%
2024 ยฃ62.69 M-127.97%
2023 -ยฃ0.23 Billion-58.25%
2022 -ยฃ0.54 Billion80.17%
2021 -ยฃ0.3 Billion
2019 -ยฃ0.15 Billion124.86%
2018 -ยฃ65.09 Million131.81%
2017 -ยฃ28.08 Million
2015 -ยฃ13.56 Million
2013 -ยฃ8.21 Million